MedTrace Logo

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

NCT03549754 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 35000

Last updated 2026-07-22

No results posted yet for this study

Summary

To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases

Conditions

Sponsors & Collaborators

Principal Investigators

  • Hardik Vasnawala, MD · AstraZeneca

  • Isidro Villanueva, MD · AstraZeneca

  • Ahmed Hadaoui, PharmD · AstraZeneca

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-17
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Brazil
  • Chile
  • Costa Rica
  • Côte d’Ivoire
  • Egypt
  • Georgia
  • Ghana
  • Hong Kong
  • India
  • Iraq
  • Kazakhstan
  • Kenya
  • Malaysia
  • Mexico
  • Nigeria
  • Philippines
  • South Africa
  • Taiwan
  • Ukraine
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03549754 on ClinicalTrials.gov